首页> 外国专利> New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease

New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease

机译:新的1H-吡唑并(3,4-b)吡啶化合物是鸟苷酸环化酶刺激剂,可用于治疗和/或预防心力衰竭,心绞痛,高渗,肺高渗,局部缺血和血管疾病

摘要

1H-Pyrazolo[3,4-b]pyridine compounds (I) and their N-oxides, salts, solvates, salts of N-oxides or solvates of N-oxides and salts, are new. 1H-Pyrazolo[3,4-b]pyridine compounds of formula (I) and their N-oxides, salts, solvates, salts of N-oxides or solvates of N-oxides and salts, are new. A : N or CR 3; R 3H, D, F, CHF 3, CF 3, (1-4C)-alkyl, cyclopropyl or cyclobutyl; L : a-CR4AR4B-(CR5AR5B) p-b; a : connection point at carbonyl group; b : connection point to pyrimidine or triazine ring; p : 0-2; either R4A, R5A : H, F, (1-4C)-alkyl or OH; and R4B, R5B : H, F, (1-4C)-alkyl or CF 3; or R4AR4BC : an oxy group, 3-6 membered carbocyclic ring or 4-6 membered heterocyclic ring; R 1H or F; and R 2benzyl substituted by 1-3 F. Independent claims are included for: (1) the preparation of (I); and (2) a medicament comprising (I) in combination with an inert, non-toxic auxiliary agent and a further active agent comprising organic nitrate, nitiric oxide donors, cGMP-phosphodiesterase inhibitors, anti-thrombotic active agents, blood pressure lowering agents and/or fat metabolism modifying agent. [Image] - ACTIVITY : Cardiant; Antianginal; Muscular-Gen.; Vasotropic; Thrombolytic; Antiarteriosclerotic; Antiarrhythmic; Antiparkinsonian; Antiinflammatory; Endocrine-Gen.; Antilipemic; Anorectic; Uropathic; Nephrotropic; Neuroprotective; Hypotensive; Respiratory-Gen.; CNS-Gen.; Nootropic; Cerebroprotective; Anticonvulsant; Antidepressant; Antibacterial; Immunosuppressive; Gastrointestinal-Gen.; Antiarthritic; Antirheumatic; Vulnerary; Hepatotropic; Virucide; Osteopathic; Ophthalmological. - MECHANISM OF ACTION : Guanylate cyclase stimulator. The ability of (I) to stimulate guanylate cyclase was tested using recombinant guanylate cyclase reporter cell line. The results showed that 2-[1-(2-fluorobenzyl)-1H- pyrazolo[3,4-b]pyridin-3-yl]-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3- d]pyrimidin-6-one exhibited a minimal effective concentration of 0.01 mu M.
机译:1 H-吡唑并[3,4-b]吡啶化合物(I)及其N-氧化物,盐,溶剂化物,N-氧化物的盐或N-氧化物和盐的溶剂是新的。式(I)的1 H-吡唑并[3,4-b]吡啶化合物及其N-氧化物,盐,溶剂化物,N-氧化物的盐或N-氧化物和盐的溶剂是新的。 A:N或CR 3>; R 3> H,D,F,CHF 3,CF 3,(1-4C)-烷基,环丙基或环丁基; L:a-CR4AR4B-(CR5AR5B)p-b; a:羰基的连接点; b:与嘧啶或三嗪环的连接点; p:0-2; R4A,R5A:H,F,(1-4C)-烷基或OH; R4B,R5B:H,F,(1-4C)-烷基或CF 3;或R4AR4BC:氧基,3-6元碳环或4-6元杂环;或R 1> H或F;独立的权利要求包括:(1)制备(I);和R 2>被1-3个F取代的苄基。 (2)药物,其包含(I)与惰性,无毒助剂和另外的活性剂组合,所述另外的活性剂包括有机硝酸盐,一氧化氮供体,cGMP-磷酸二酯酶抑制剂,抗血栓形成活性剂,降血压剂和/或脂肪代谢调节剂。 [图片]-活动:Cardiant;抗心绞痛肌肉型;变压性溶栓;抗动脉硬化;抗心律不整;反帕金森病;消炎(药;内分泌根抗血脂;厌食的;尿毒症;嗜肾具有神经保护作用;降压;呼吸器; CNS-Gen .;促智;脑保护抗惊厥药;抗抑郁药抗菌;免疫抑制胃肠源抗关节炎抗风湿;伤药;肝杀病毒剂;整骨;眼科的-作用机理:鸟苷酸环化酶刺激剂。 (I)刺激鸟苷酸环化酶的能力使用重组鸟苷酸环化酶报道细胞系进行了测试。结果显示2- [1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-基] -5,5-二甲基-5,7-二氢-6H-吡咯并[2, 3- d]嘧啶-6-酮的最小有效浓度为0.01μM。

著录项

  • 公开/公告号DE102010031149A1

    专利类型

  • 公开/公告日2012-01-12

    原文格式PDF

  • 申请/专利权人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT;

    申请/专利号DE20101031149

  • 发明设计人 ERFINDER WIRD SPÄTER GENANNT WERDEN;

    申请日2010-07-09

  • 分类号C07D471/04;A61P9/10;A61K31/519;A61P9/00;A61K31/506;A61K31/53;A61P9/12;A61P9/14;

  • 国家 DE

  • 入库时间 2022-08-21 17:05:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号